CHF Solutions, Inc. Strengthens Sales Force with Senior Director of US Sales

EDEN PRAIRIE, Minn., Feb. 06, 2018 -- CHF Solutions, Inc. (NASDAQ:CHFS), today announces the appointment of Richard E. Roberts as its senior director of U.S. sales, who will lead the US sales force for the company’s Aquadex FlexFlow System.

Mr. Roberts brings significant medical sales leadership experience to his position overseeing the US sales organization.  Prior to this position, he founded and ran Gen Wellness, a physician-focused contract sales organization.  Before that, he served in multiple management and sales positions at Cardiovascular Systems, Inc., Boston Scientific, Inc. and Forest Laboratories, Inc.

“Hiring Richard continues to build the leadership team for our United States sales force and strengthens our efforts to provide our current and future customers with the highest level of service in order to maximize their use of our products,” said John Erb, president, CEO and chairman of CHF Solutions, Inc.  “We continue to be dedicated to expanding utilization within our current customer base while seeking new accounts in which to introduce the Aquadex FlexFlow System.”

About CHF Solutions

CHF Solutions, Inc. (NASDAQ:CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow system for Aquapheresis® therapy. The Aquadex FlexFlow system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies. The company's mission is to predict, measure, and control patient fluid balance through science, collaboration, and innovative medical technology. CHF Solutions is a Delaware corporation headquartered in Minneapolis, Minnesota with wholly owned subsidiaries in Australia and Ireland. The company has been listed on the NASDAQ Capital Market since February 2012.

CONTACTS:

INVESTORS:
Claudia Napal Drayton
Chief Financial Officer
CHF Solutions, Inc.
952-345-4205
[email protected]

-or-
Bret Shapiro
Managing Partner
CORE IR
516-222-2560
[email protected]
www.coreir.com

MEDIA
Jules Abraham
JQA Partners, Inc.
917-885-7378
[email protected]